JA2-WP5 EUnetHTA Joint Action 2 (2012-15)
2015 - PDF

 

The purpose of the assessment is to evaluate multiple new pharmaceuticals for the treatment of Chronic Hepatitis C.

Final version of the assessment was published in December 2015

Below is the documentation provided by the Joint Assessment authoring team: